Warning: The NCBI web site requires JavaScript to function. more...
Weill Medical College of Cornell University and the Bipolar Disorders Research Clinic, Payne Whitney Clinic-New York Presbyterian Hospital, New York, USA. JFGoldbe@mail.med.cornell.edu
The increasing use of anticonvulsant drugs in psychiatry has prompted greater awareness of their effects on a range of psychiatric domains, including cognition. Older versus newer antiepileptic drugs have been reported to either worsen or enhance cognitive performance in clinical populations, and the extent to which cognitive disturbances may reflect iatrogenic factors versus psychopathology is subject to debate. We review current information about the role of anticonvulsants in cognition, with particular emphasis on newer compounds (such as lamotrigine, gabapentin, and topiramate), the cognitive dimensions of affective illness, and the clinical approach to evaluating cognition in psychiatric patients taking anticonvulsant drugs over time.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on